Initial experiences with a 980 nm diode laser for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia

Korean Journal of Urology

Volumn 52, Issue 11, 2011, Pages 752-756

  Yang, Ki Su ^a   Seong, Youl Keun ^a   Kim, In Gon ^a   Han, Bo Hyun ^a   Kong, Geun Soo ^b  

^a Maryknoll Hospital   (South Korea)

^b Boomin Hospital   (South Korea)

Author keywords

Lasers; Prostatic hyperplasia; Urodynamics

Indexed keywords

ADULT; AGED; ARTICLE; CATHETERIZATION; DIODE LASER; DYSURIA; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MORBIDITY; OPERATION DURATION; PHOTOSELECTIVE VAPORIZATION; POSTOPERATIVE PERIOD; POSTVOID RESIDUAL URINE VOLUME; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINE FLOW RATE;

EID: 84255162160     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.11.752     Document Type: Article

References (21)

1. McNeal J. Pathology of benign prostatic hyperplasia insight into etiology. Urol Clin North Am 1990;17:477-86.
2. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assesment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547-54.
3. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006;50:969-79.
4. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
5. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180:246-9.
6. Donovan JL, Peters TJ, Neal ED, Brookes ST, Gujral S, Chacko KN, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the CLasP study. J Urol 2000;164:65-70.
7. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172: 1404-8.
8. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71.
9. Spaliviero M, Araki M, Page JB, Wong C. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med 2008;40:529-34.
10. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60.
11. Sarica K, Alkan E. Lüleci H, Taşci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005;19:1199-202.
12. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, et al. Short term outcomes of high power (80W) potassium-titanyl-phosphate laser vaporization of the prostate. EUR Urol 2005;48:608-13.
13. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004;18:976-81.
14. Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008;102:1432-9.
15. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010;105:964-9.
16. Kang SH, Choi SY, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Long-term follow-up results of photoselective vaporization of the prostate with the 120 W greenlight HPS laser for treatment of be-nign prostatic hyperplasia. Korean J Urol 2011;52:260-4.
17. Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, et al. The diode laser: A novel side firing approach for laser vaporisation of the human prostate-immediate efficacy and 1-year follow-up. Eur Urol 2007;52:1717-22.
18. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, et al. 980-nm Diode laser: A novel laser technology for vaporization of the prostate. Eur Urol 2007;52:1723-8.
19. Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 2009;182:1078-82.
20. Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009;104: 820-5.
21. Seitz M, Reich O, Gratzke C, Schlenker B, Khoder W, Fischer F, et al. High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 2009;24:172-8.